{
  "description": "Kinds of issues or contraindications, such as 'drug-drug interaction', 'duplicate therapy', etc.",
  "compose": {
    "include": [ {
      "filter": [ {
        "op": "is-a",
        "value": "_AdministrationDetectedIssueCode",
        "property": "concept"
      } ],
      "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode"
    }, {
      "filter": [ {
        "op": "is-a",
        "value": "_ActSuppliedItemDetectedIssueCode",
        "property": "concept"
      } ],
      "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode"
    }, {
      "filter": [ {
        "op": "is-a",
        "value": "_SupplyDetectedIssueCode",
        "property": "concept"
      } ],
      "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode"
    } ]
  },
  "_filename": "ValueSet-detectedissue-category.json",
  "package_name": "hl7.fhir.r4b.core",
  "date": null,
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset" ],
    "lastUpdated": "2021-03-11T17:06:20.662+11:00"
  },
  "publisher": "FHIR Project team",
  "name": "DetectedIssueCategory",
  "type": null,
  "experimental": null,
  "resourceType": "ValueSet",
  "title": "Detected Issue Category",
  "package_version": "4.1.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode": "cds"
  } ],
  "status": "draft",
  "id": "d3d69a51-afcc-4cfe-a5d4-65c0b177ffbe",
  "kind": null,
  "url": "http://hl7.org/fhir/ValueSet/detectedissue-category",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113883.4.642.3.204",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "4.1.0",
  "contact": [ {
    "telecom": [ {
      "value": "http://hl7.org/fhir",
      "system": "url"
    } ]
  } ]
}